Rangeley Capital's Portfolio Managers, Chris DeMuth and Andrew Walker, discuss Ares (ARES) deal to buy American Capital (ACAS) and then dive into the big month in healthcare mergers, including Icahn's new stake in Allergan (AGN) and a bit more on the Medivation (MDVN) bidding war.